Investors

Early Capital seeks to match equity capital with an outstanding business plan, a proven management team and a strategy that can blossom into a profitable business. Our firm is exposed to hundreds of new business concepts every month. Only the best proposals are forwarded to our select investor membership.

During the application process, prospective member investors will be asked to verify their accreditation status, as defined by the Securities and Exchange Commission (see Rule 501 of Regulation D). In order to comply with US securities regulations, all member investors must complete the accreditation documentation. Our broker/dealer affiliate will deliver additional documents to member investors requesting information.

Early Capital regards all investor information as confidential, if you have any further questions please see our Privacy Statement.


 

 

 

Copyright 2005 The Venture Alliance. All rights reserved. Privacy Statement

Site maintained by webmaster@earlycapital.com

   

 

 

 

accredited investor,acquisition,angel funding,angel investors,Biotech,business plan,California,capital raising,Chemicals,corporate capital,corporate finance,deal source,dealflow,Drugs,Early Capital,Electronics,Energy,Engineering,entrepreneur,entrepreneurs,executive summary,funding,institutional capital,institutional funds,investment bank,investment banking,Life Sciences,M&A,Manufacture,merger,mezzanine,Pharmaceuticals,PPM,pre-ipo,private capital,private equity,private placements,qualified deals,qualified investors,Retail,Risikokapital,San Diego,Science,screened deal,Software,startup,start-up capital,startups,Telecom,Utilities,VC capital,VC funding,venture capitalaccredited investor,acquisition,angel funding,angel investors,Biotech,business plan,California,capital raising,Chemicals,corporate capital,corporate finance,deal source,dealflow,Drugs,Early Capital,Electronics,Energy,Engineering,entrepreneur,entrepreneurs,executive summary,funding,institutional capital,institutional funds,investment bank,investment banking,Life Sciences,M&A,Manufacture,merger,mezzanine,Pharmaceuticals,PPM,pre-ipo,private capital,private equity,private placements,qualified deals,qualified investors,Retail,Risikokapital, San Diego,Science,screened deal,Software,startup,start-up capital,startups,Telecom,Utilities,VC capital,VC funding,venture capital